Suchergebnisse - "Trappe, Ralf Ulrich"

PubPharm (39)

1

Post-transplantation Burkitt lymphoma : a retrospective study of 55 patients

enthalten in: Haematologica | 2023

von Walczak, P. | Choquet, S. | Dantal, J. | +28

2

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors

enthalten in: The Journal of clinical investigation | 2023

von Bonifacius, A. | Lamottke, B. | Tischer-Zimmermann, S. | +34

3

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

enthalten in: The New England journal of medicine | 2023

von Eichhorst, B. | Niemann, C. | Kater, A. | +148

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):503. - PMID 37237098

4

Peri-operative ovarian cancer guidelines : major intra-operative and post-operative bleeding and thromboembolic events

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2022

von Fotopoulou, C. | Haidopoulos, D. | Trappe, R.

5

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia

enthalten in: HemaSphere | 2022

von Kutsch, N. | Pallasch, C. | Tausch, E. | +17

6

The EHA research roadmap : malignant lymphoid diseases

enthalten in: HemaSphere | 2022

von Dreyling, M. | André, M. | Gökbuget, N. | +51

7

The EHA Research Roadmap : Malignant Lymphoid Diseases

enthalten in: HemaSphere | 2022

von Dreyling, M. | André, M. | Gökbuget, N. | +51

8

Rationale and design of the 2 by 2 factorial design GnG-trial : a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML

enthalten in: Trials | 2021

von Jaramillo, S. | Krisam, J. | Le Cornet, L. | +32

9

Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML

enthalten in: Trials | 2021

von Jaramillo, S. | Krisam, J. | Le Cornet, L. | +32

10

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Fotopoulou, C. | Planchamp, F. | Aytulu, T. | +16

CommentIn: Int J Gynecol Cancer. 2021 Sep;31(9):1207-1208. - PMID 34407961